Adam Bonislawski
Adam covers proteomics and the clinical lab market for GenomeWeb.

Articles Authored by Adam Bonislawski
The method combines tissue clearing and high-sensitivity mass spec to enable identification and proteomic profiling of affected cells early in a disease process.
The Stanford researcher and his colleagues have launched a pair of companies, Iollo and RHTM, to commercialize the approach.
Cedars Sinai Team Develops Method for Quantitative Label-Free Proteomics Without LC Separation
Premium
Such direct infusion mass spec workflows are niche within proteomics, but sample handling and ion mobility advances could drive future adoption.
While deals got done, it was a far cry from the boom times of 2021, with firms becoming more circumspect as they anticipated a possible recession and falling valuations.
For proteomics firms, 2022 marked a reversal from an earlier boom, but the field pushed into emerging areas like single-cell, single-molecule, and spatial analyses.
CEO Michael Egholm, a former Danaher exec, said he sees Standard BioTools' flaws as emblematic of problems hampering the broader life science tools industry.
With $6M in Seed Funding, Swedish Startup Pixelgen Developing Tech to Map Cell Surface Proteins
Premium
Cofounded by a former Olink executive, the firm uses DNA-linked antibodies for highly multiplexed identification and localization of cell surface proteins.
Human Protein Atlas Using Olink Tech to Move Into Plasma Proteomic Profiling of Disease States
Premium
Called the Human Disease Blood Atlas, the project aims to profile roughly 10,000 individuals a year, amounting to annual Olink assay costs of more than $5 million.
Navignostics Using Single-Cell Spatial Proteomics to Guide Oncology Treatment, Drug Development
Premium
The University of Zurich spinout is using Standard BioTools' Hyperion system for its analyses and recently raised CHF 7.5 million in seed funding.
The increasing speed of mass spec instruments and the move toward analysis of extremely small samples are prompting some to give CE a look.
